VWF A1 domain, Human (Caplacizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-VWF A1 domain, Human (Caplacizumab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityVWF A1 domain, Human (Caplacizumab biosimilar)
CloneCaplacizumab
Host SpeciesRecombinant
Reactive Specieshuman
IsotypeVH-VH
Formatpurified
Size1mg, 5mg
Concentration1mg/ml
Applicationsn/a
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Human VWF A1 domain Recombinant Antibody. Caplacizumab (INN, trade name Cablivi) is a bivalent single-domain antibody (VHH) designed for the treatment of thrombotic thrombocytopenic purpura and thrombosis.
Immunogenn/a
Other NamesAnti-VWF A1 domain Recombinant Antibody, Research Grade Caplacizumab, Anti-Human VWF A1 domain Recombinant Antibody, ALX-0081, PMP12A2h1-linker AAA-PMP12A2h1, Antibody Drug Analogues, Monoclonal Antibody, YR1265, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 915810-67-2
Catalog #YR1265
Priceplease inquire
Order / More InfoVWF A1 domain, Human (Caplacizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.